Ningxia Hengkang Technology Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is METFORMIN HYDROCHLORIDE (2ND LINE), with a corresponding US DMF Number 39624.
Remarkably, this DMF maintains an Active status since its submission on March 26, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 30, 2024, and payment made on June 06, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II